Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Combining two multiple sclerosis treatments has no clinical benefit, study finds.

Anekwe L.

BMJ. 2013 Mar 14;346:f1719. doi: 10.1136/bmj.f1719. No abstract available.

PMID:
23491460
[PubMed - indexed for MEDLINE]
2.

Consensus statement of the Canadian MS CLinics Network on: the use of disease modifying agents in multiple sclerosis.

Oger J, Freedman M.

Can J Neurol Sci. 1999 Nov;26(4):274-5. Review. English, French. No abstract available.

PMID:
10610197
[PubMed - indexed for MEDLINE]
3.

Interferon beta and glatiramer acetate therapy.

McGraw CA, Lublin FD.

Neurotherapeutics. 2013 Jan;10(1):2-18. doi: 10.1007/s13311-012-0163-4. Review.

PMID:
23264098
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Use of interferon-beta in the treatment of multiple sclerosis.

Derwenskus J, Lublin FD.

Adv Neurol. 2006;98:257-71. Review. No abstract available.

PMID:
16400838
[PubMed - indexed for MEDLINE]
5.

Concomitant therapy for multiple sclerosis.

Stuart WH, Vermersch P.

Neurology. 2004 Dec 14;63(11 Suppl 5):S28-34. Review.

PMID:
15596733
[PubMed - indexed for MEDLINE]
6.

Approaches to neuroprotective strategies in multiple sclerosis.

Tselis A, Khan OA, Lisak RP.

Expert Opin Pharmacother. 2010 Dec;11(17):2869-78. doi: 10.1517/14656566.2010.508070. Epub 2010 Aug 5. Review.

PMID:
20687779
[PubMed - indexed for MEDLINE]
7.

Newer long-term treatments for multiple sclerosis.

Pryse-Phillips W.

Clin Neurol Neurosurg. 2002 Jul;104(3):265-71. Review. No abstract available.

PMID:
12127666
[PubMed - indexed for MEDLINE]
8.

A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.

Nikfar S, Rahimi R, Abdollahi M.

Clin Ther. 2010 Oct;32(11):1871-88. doi: 10.1016/j.clinthera.2010.10.006. Review.

PMID:
21095482
[PubMed - indexed for MEDLINE]
9.

A practical approach to immunomodulatory therapy for multiple sclerosis.

Burks JS.

Phys Med Rehabil Clin N Am. 2005 May;16(2):449-66, ix. Review.

PMID:
15893681
[PubMed - indexed for MEDLINE]
10.

[Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis].

Losy J.

Neurol Neurochir Pol. 2000;34(3 Suppl):63-9. Review. Polish.

PMID:
10983302
[PubMed - indexed for MEDLINE]
11.

A practical guide to pediatric multiple sclerosis.

Huppke P, Gärtner J.

Neuropediatrics. 2010 Aug;41(4):157-62. doi: 10.1055/s-0030-1267155. Epub 2010 Nov 17. Review.

PMID:
21086219
[PubMed - indexed for MEDLINE]
12.

Multiple sclerosis.

Boggild M, Ford H.

Clin Evid. 2004 Dec;(12):1843-60. Review. No abstract available. Update in: Clin Evid. 2005 Dec;(14):1637-51.

PMID:
15865753
[PubMed - indexed for MEDLINE]
13.

[Drug therapy of multiple sclerosis].

Kinnunen E.

Duodecim. 1999;115(4):403-7. Review. Finnish. No abstract available.

PMID:
11830889
[PubMed - indexed for MEDLINE]
14.

[Neuroprotective effect of the long-term beta-interferon course in multiple sclerosis: direct and indirect mechanisms].

Gusev EI, Boĭko AN, Khachanova NV, Demina TL, Davydovskaia MV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(6):70-3. Review. Russian. No abstract available.

PMID:
16841488
[PubMed - indexed for MEDLINE]
15.

Spotlight on: clinical development of mycophenolate mofetil in multiple sclerosis.

Davies SL, Moral MA.

Drug News Perspect. 2006 Dec;19(10):632-3. Review.

PMID:
17299605
[PubMed - indexed for MEDLINE]
16.

Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice.

Costello F, Stüve O, Weber MS, Zamvil SS, Frohman E.

Curr Opin Neurol. 2007 Jun;20(3):281-5. Review.

PMID:
17495621
[PubMed - indexed for MEDLINE]
17.

[Problems and prospects of beta-interferon and copaxone++ application in the treatment of multiple sclerosis].

Gusev EI, Boĭko AN, Pozer Ch.

Zh Nevrol Psikhiatr Im S S Korsakova. 1999;99(4):33-6. Review. Russian. No abstract available.

PMID:
10319395
[PubMed - indexed for MEDLINE]
18.

Control of multiple sclerosis relapses with immunomodulating agents.

Johnson KP.

J Neurol Sci. 2007 May 15;256 Suppl 1:S23-8. Epub 2007 Mar 12. Review.

PMID:
17350652
[PubMed - indexed for MEDLINE]
19.

Multiple sclerosis.

Ford H, Nicholas R.

Clin Evid. 2005 Dec;(14):1637-51. Review. No abstract available.

PMID:
16620466
[PubMed - indexed for MEDLINE]
20.

Why treat early multiple sclerosis patients?

Comi G.

Curr Opin Neurol. 2000 Jun;13(3):235-40. Review.

PMID:
10871245
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk